Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Kline and French Laboratories Ltd
Original Assignee
Smith Kline and French Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline and French Laboratories LtdfiledCriticalSmith Kline and French Laboratories Ltd
Priority to ES0262144ApriorityCriticalpatent/ES262144A1/en
Publication of ES262144A1publicationCriticalpatent/ES262144A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
Process for preparing a medicinal composition, comprising the addition of a 6-aryl-2,4,7-triaminopteridine to a pharmaceutical excipient. (Machine-translation by Google Translate, not legally binding)
ES0262144A1960-11-021960-11-02Process of preparation of a medicinal composition (Machine-translation by Google Translate, not legally binding)
ExpiredES262144A1
(en)
Improvements introduced in the preparation of pharmaceutical compositions in the form of unit dose (Machine-translation by Google Translate, not legally binding)
Procedure for the obtaining of a composition used as excipient in pharmaceutical preparations. (Machine-translation by Google Translate, not legally binding)
A procedure for the preparation of 5-fluor-2-methyl-1- (p-metilsulfinilbenciliden) -3-indenil-acetic acid. (Machine-translation by Google Translate, not legally binding)